Corporate information
Official name
Armo BioSciences Inc
Company type
Late-stage immuno-oncology company.Funding rounds
Series C-1 USD 67,000,000
USD 67,000,000 ( )
"The Series C-1 proceeds will be used to initiate phase 2/3 studies with ARMO’s lead immunotherapy agent AM0010 in non-small cell lung cancer and renal cell cancer and to support an ongoing pivotal phase 3 clinical trial in advanced pancreatic cancer. The
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Qiming Venture Partners | Initial investment. Led the round. | ||
|
Decheng Capital (德诚资本) | Initial investment. | ||
|
Quan Capital Ltd | Alternative investment firm with a focus on control-oriented investments in small- and medium-sized enterprises. | Initial investment. | |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
RTW Investments | Initial investment. | ||
|
Sequoia Capital Operations LLC (Sequoia) | Venture capital firm. | Initial investment. | |
|
|
Celgene Corp | Biopharmaceutical company committed to improving the lives of patients worldwide. | Follow-on investment. | |
|
|
Clough Capital Partners LP | Follow-on investment. | ||
|
Duff Ackerman & Goodrich Ventures (DAG Ventures) | A mid-stage venture capital partnership with a service-oriented mindset. | Follow-on investment. | |
|
GV. | The venture capital arm of Alphabet Inc. (Formerly Google Ventures.) | Follow-on investment. | |
|
|
HBM Healthcare Investments | Follow-on investment. | ||
|
Kleiner Perkins Caufield & Byers LLC (KPCB) | Venture capital firm. | Follow-on investment. | |
|
NanoDimension Inc (ND Capital) | Follow-on investment. | ||
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | Follow-on investment. |
Investment activity status
Active investor